Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Cardiovascular disease is a leading cause of morbidity in patients with chronic kidney disease, particularly around the time of kidney transplantation. In the absence of a universal protocol for pre-operative cardiac screening, clinical practice varies significantly. This study analyses the cardiac evaluation protocols and their outcomes for transplant recipients at our centre.
This retrospective analysis included 296 patients who underwent renal transplantation between 2004 and 2019 at Sri Jayewardenepura General Hospital. Data were collected from clinic records and bedhead tickets.
Among 296 patients, 21 had a reduced ejection fraction (EF<50%). Of these, 13 underwent coronary angiography (CAG), which identified coronary artery disease (CAD) in 11, with 6 requiring revascularization. 8 patients with no additional risk factors underwent no further evaluation.
Among 266 patients with EF >50%:
o 115 had Diabetes Mellitus (DM):
§ 27 with a history of IHD all underwent coronary angiogram (CAG): 14 had triple vessel disease (TVD), 4 had double vessel disease (DVD), 3 had single vessel disease (SVD), and 6 had minor plaque disease. Revascularization was required in 20 (10 CABG, 10 PCI).
§ 88 without prior IHD:
§ 30 aged >55 years: 29 underwent CAG (2 TVD, 2 DVD, 7 SVD, 15 minor plaque, 3 normal). Revascularization (PCI) was required in 7, CABG in 1. One patient underwent ETT with negative result.
§ 58 aged <55 years: 38 underwent CAG, with 6 requiring revascularization.
o 151 were Non-Diabetic:
§ 5 with a history of IHD all underwent screening; 1 ETT and CAG in other 4. One had TVD requiring CABG.
§ 146 without prior IHD:
§ 19 patients >55 years underwent screening (16 CAG, 3 ETT). CAG revealed 6 SVD, 1 DVD, 6 minor plaque, and 3 normal coronaries. Only 3 required revascularization.
§ 127 patients < 55 years only 16% (n=21/127) were screened and only 3 needed revascularization (3 PCI for SVD).
Overall, 44% patients underwent coronary angiography. Of those who underwent CAG, 36% required an intervention. From the screened patients, most had minor plaque disease (48%) or normal coronaries (22%), and 64% did not require intervention. Although 78% of coronary angiographies showed positive findings, only 36% of patients required revascularization, with others managed medically.
This study emphasises the importance of standardised risk stratification in renal transplant candidates to minimise unnecessary invasive investigations while ensuring optimal detection of significant CAD. It highlights the high prevalence of occult CAD, particularly among diabetics, older age patients (>55 years), and those with a history of CAD, reinforcing the need for targeted preoperative cardiac screening in this high-risk cohort. Establishing cardiac risk stratification guidelines are particularly helpful for the resource poor setting where health economics can be directed to be used more cost effectively.
